Pharmaceuticals, Biotechnology and Life Sciences
SAN FRANCISCO–(BUSINESS WIRE)–Circle Medical, a digital-first primary care practice, will be offering a convenient at home COVID-19 self-collection test kit in partnership with Labcorp (NYSE: LH). Together with Circle Medical’s primary care telemedic…
Dr. Chandel brings decades of research expertise as the company advances its novel Mitochondria Modifying Agent oncology research program
ANN ARBOR, Mich. & CHICAGO–(BUSINESS WIRE)–Penrose TherapeuTx, a pharmaceutical company focused on developing i…
Dr. Chandel brings decades of research expertise as the company advances its novel Mitochondria Modifying Agent oncology research program
ANN ARBOR, Mich. & CHICAGO–(BUSINESS WIRE)–Penrose TherapeuTx, a pharmaceutical company focused on developing i…
Dr. Chandel brings decades of research expertise as the company advances its novel Mitochondria Modifying Agent oncology research program
ANN ARBOR, Mich. & CHICAGO–(BUSINESS WIRE)–Penrose TherapeuTx, a pharmaceutical company focused on developing i…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically screen the whole genome to identify optimal gene targets for oncology and autoimmune disease, today ann…
Dr. Chandel brings decades of research expertise as the company advances its novel Mitochondria Modifying Agent oncology research program
ANN ARBOR, Mich. & CHICAGO–(BUSINESS WIRE)–Penrose TherapeuTx, a pharmaceutical company focused on developing i…
CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the first patie…
Analyses demonstrate lentiviral vector BB305 unlikely to be the cause of AML in clinical study of LentiGlobin for SCD
bluebird bio has initiated process with regulators to resume clinical studies
Company to hold conference call and webcast today, Ma…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically screen the whole genome to identify optimal gene targets for oncology and autoimmune disease, today ann…
CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–$BGNE #BTKi–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the first patie…